Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal dominant disorder caused by pathogenic variation in SOX11 characterized by developmental delay, impaired intellectual development and microcephaly. Affected individuals may also have oculomotor apraxia, ocular malformations including coloboma, lens abnormalities and microphthalmia, and hypogonadotropic hypogonadism. Some patients may have finger clinodactyly and hypoplastic distal phalanges with nail hypoplasia, especially of the fifth digits. Individuals with variants in SOX11 have a "unique peripheral blood DNA methylation signature as a diagnostic biomarker and phenotypic clustering analysis that distinguishes SOX11 syndrome from BAFopathies.
Biomarker and diagnostic research for SOX11-related complex neurodevelopmental disorder with or without congenital anomalies has been reported in the published literature.
No clinical trials have been registered for SOX11-related complex neurodevelopmental disorder with or without congenital anomalies.
202 publications have been identified in PubMed for SOX11-related complex neurodevelopmental disorder with or without congenital anomalies. Kisho has analyzed 85 by research type. Research spans Review / Meta-Analysis (51%), Epidemiology / Natural History (36%), and Case Report / Case Series (6%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 43 |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 9:54 AM UTC
Common questions about SOX11-related complex neurodevelopmental disorder with or without congenital anomalies
Disease patterns and progression | 31 | 36% |
Patient case studies | 5 | 6% |
Testing and diagnosis research | 2 | 2% |
Laboratory research | 2 | 2% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Rosh B (2026). [PMID: 41715957](https://pubmed.ncbi.nlm.nih.gov/41715957/). *Clin Pharmacol Ther*. [Epidemiology / Natural History]
Musante L (2026). [PMID: 41709284](https://pubmed.ncbi.nlm.nih.gov/41709284/). *Genome Med*. [Basic Science / Preclinical]
Milne B (2026). [PMID: 42114909](https://pubmed.ncbi.nlm.nih.gov/42114909/). *CMAJ*. [Epidemiology / Natural History]
Li J (2026). [PMID: 41556511](https://pubmed.ncbi.nlm.nih.gov/41556511/). *Clin Genet*. [Review / Meta-Analysis]
Langer S (2026). [PMID: 41513036](https://pubmed.ncbi.nlm.nih.gov/41513036/). *J Pediatr Surg*. [Review / Meta-Analysis]
Cospain A (2025). [PMID: 41118103](https://pubmed.ncbi.nlm.nih.gov/41118103/). *J Assist Reprod Genet*. [Diagnostic / Biomarker]
Han S (2025). [PMID: 40437108](https://pubmed.ncbi.nlm.nih.gov/40437108/). *Pediatr Nephrol*. [Epidemiology / Natural History]
Merz LM (2025). [PMID: 40223730](https://pubmed.ncbi.nlm.nih.gov/40223730/). *Genet Med*. [Epidemiology / Natural History]
Çaltek HÖ (2025). [PMID: 40405073](https://pubmed.ncbi.nlm.nih.gov/40405073/). *BMC Pregnancy Childbirth*. [Epidemiology / Natural History]
Keçeci R (2025). [PMID: 40650423](https://pubmed.ncbi.nlm.nih.gov/40650423/). *Birth Defects Res*. [Epidemiology / Natural History]